EQ
Equillium, Inc.
There isn't enough reported data to score EQ yet.
EQ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
EQ's revenue is currently stable, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
EQ PE Valuation
EQ has no meaningful PE right now: it lost money over the past year.
EQ Forward outlook
There aren't enough analyst estimates for EQ to show an outlook.
EQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.20 | +$0.42 |
| Q2 2026 | -$0.22 | +$0.34 |
| Q1 2026 | -$0.34 | +$0.05 |
| Q4 2025 | -$0.52 | -$0.29 |
| Q3 2025 | -$0.62 | -$0.49 |
| Q2 2025 | -$0.56 | -$0.32 |
| Q1 2025 | -$0.39 | -$0.04 |
| Q4 2024 | -$0.23 | +$0.15 |
EQ is still losing money, but far less than before: $0.20 per share over the past year, against $2.35 at its worst in late 2022.
EQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $4.4M | -52% |
| Q3 2024 | $12.2M | +37% |
| Q2 2024 | $13.9M | +52% |
| Q1 2024 | $10.7M | +20% |
EQ's revenue is growing: $4M last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -107% | -72 points |
| Q3 2024 | -5.6% | +35 points |
| Q2 2024 | -0.7% | +39 points |
| Q1 2024 | -26% | +20 points |
| Q4 2023 | -35% | N/A |
| Q3 2023 | -41% | N/A |
| Q2 2023 | -39% | N/A |
| Q1 2023 | -46% | N/A |
EQ's operating margin was −107% last quarter, down 72 points from the same quarter a year ago, near the bottom of its range since 2023.
EQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.8M | +$4.6M |
| Q2 2026 | -$4.2M | -$1.2M |
| Q1 2026 | -$4.3M | +$3.9M |
| Q4 2025 | -$3.2M | +$126K |
| Q3 2025 | -$8.4M | -$774K |
| Q2 2025 | -$3M | -551% |
| Q1 2025 | -$8.2M | +$646K |
| Q4 2024 | -$3.3M | +$2.4M |
EQ has burned cash in almost every quarter: −$15M over the past year, against −$23M the year before.
EQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +118K shares |
| 1 year | +71% | +46.6M shares |
| 3 years | +221% | +77M shares |
| 5 years | +281% | +82.5M shares |
| Available history | +544% | +94.5M shares |
EQ has 112M diluted shares, up 71% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
EQ Net Leverage
EQ's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.6 | Neutral |
| Stochastic | 15.7 | Oversold |
EQ's weekly RSI is 37 (neutral) and its Stochastic is 16 (oversold).
EQ PE vs Healthcare Sector
EQ has no meaningful PE right now: it lost money over the past year.
EQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.39 | 5% below |
| 20 week MA | $1.98 | 33% below |
| 50 week MA | $1.94 | 32% below |
| 100 week MA | $1.38 | 4.3% below |
| 200 week MA | $1.19 | 11% above |
EQ has fallen below most of its moving averages, though it's still 11% above its 200-week average.
EQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.03 | $4.66 | +16% |
| 2021 | $4.66 | $4.49 | -3.6% |
| 2022 | $4.49 | $0.89 | -80% |
| 2023 | $0.89 | $0.72 | -19% |
| 2024 | $0.72 | $0.69 | -4.2% |
| 2025 | $0.69 | $1.50 | +117% |
| 2026 YTD | $1.50 | $1.32 | -12% |
EQ's yearly returns have swung widely, from +117% in 2025 to −80% in 2022. It's down 12% so far in 2026.